Semester of Graduation
First Major Professor
Master of Science (MS)
SARS-CoV-2 is a coronavirus that causes the disease COVID-19. It was initially reported to have been the cause of several abnormal pneumonia cases in Wuhan China. Shortly after emerging from Wuhan, it was transmitted throughout China in late 2019 and continued to spread throughout the world causing economic disruption, severe stress on health care systems, prolific death, and upending life as it is known. The emergence of SARS-CoV-2 and its ramifications triggered a race to create a safe and effective vaccine in order to limit death, infection and restore a more normal way of life. Since the genome of the virus was sequenced in early January of 2020, more than 250 vaccine candidates have begun development, several of which have received Emergency Use Authorizations (EUAs) and begun administration at mass scales throughout the world.
Embargo Period (admin only)
Bymark, Jeff, "SARS-CoV-2 Vaccine Development" (2021). Creative Components. 715.